While the global animal vaccine market is an $8 billion industry, most of that is driven by the pet industry. Food producers and government agencies are expressing the dire need for new product development for emerging diseases in food animals. The big companies aren't doing it. The small companies are inefficient.
Which leaves the door wide open for Medgene Labs.
High profile diseases are making media headlines around the world and the increase in global disease transmission makes the timing right for Medgene Labs to produce, market and distribute products focused on emerging food animal diseases.
Public fear of diseases like Rift Valley Fever, Porcine Epidemic Diarrhea and West Nile make the development of vaccines for these diseases not only important to the world, but lucrative to investors as well.